Published in Proc Soc Exp Biol Med on November 01, 1955
Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J (1958) 6.30
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol (2003) 2.40
Poliomyelitis and other enteric viruses in sewage. Am J Public Health Nations Health (1957) 1.77
Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother (2013) 1.31
Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol (2012) 1.16
Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg Infect Dis (2011) 1.15
Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One (2014) 1.13
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol (2012) 1.00
Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A (2013) 0.99
THE MAMMALIAN CELL-VIRUS RELATIONSHIP : V. SUSCEPTIBILITY AND RESISTANCE OF CELLS IN VITRO TO INFECTION BY COXSACKIE A9 VIRUS. J Exp Med (1960) 0.97
Circulating HFMD-associated coxsackievirus A16 is genetically and phenotypically distinct from the prototype CV-A16. PLoS One (2014) 0.95
Outbreak of aseptic meningitis (meningoencephalitis) with rubelliform rash: Toronto, 1956. Can Med Assoc J (1957) 0.87
Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice. J Virol (2015) 0.82
Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother (2015) 0.79
The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems. Hum Vaccin Immunother (2014) 0.78
Complete sequence analysis and antiviral screening of medicinal plants for human coxsackievirus a16 isolated in Korea. Osong Public Health Res Perspect (2015) 0.78
Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol (2016) 0.76
Diverticulum of the female urethra; an overlooked condition. Can Med Assoc J (1958) 0.75
ASEPTIC meningitis with rash. Can Med Assoc J (1957) 0.75
A virus recovered from the feces of poliomyelitis patients pathogenic for suckling mice. J Exp Med (1949) 2.92
Production of specific antisera for enzymes that decompose the carbohydrates of pneumococcus types III and VIII. J Immunol (1950) 2.21
The Coxsackie viruses. Ann N Y Acad Sci (1962) 1.40
Serologic differences among strains of the Coxsackie group of viruses. Proc Soc Exp Biol Med (1949) 1.22
A newly-recognized enterovirus isolated from cases of aseptic meningitis. Am J Hyg (1963) 1.17
Isolation and type determination of Coxsackie virus, group B, in tissue culture. Proc Soc Exp Biol Med (1955) 1.09
Coxsackie B-5 pericarditis in pregnancy. Arch Intern Med (1962) 1.06
New types of Coxsackie virus, group A. Cytopathogenicity in tissue culture. Proc Soc Exp Biol Med (1960) 1.05
Production of specific pneumococcus carbohydrate-splitting enzymes in media to which the specific substrate was not added. J Immunol (1950) 0.96
Antibody response to two different live poliomyelitis virus vaccines. N Y State J Med (1962) 0.85
ENTEROVIRUS TYPING BY COMPLEMENT FIXATION. Proc Soc Exp Biol Med (1964) 0.81
Paralysis associated with ECHO virus type nine. N Y State J Med (1961) 0.79
Effect of pH on MM virus. Proc Soc Exp Biol Med (1948) 0.75
Methods of testing immune sera. Annu Rep N Y State Dept Health Division Lab Res (1946) 0.75
Investigation of virus infection. Annu Rep N Y State Dept Health Division Lab Res (1946) 0.75